TipRanks
Phathom Pharmaceuticals (PHAT)
NASDAQ:PHAT
US Market
PHAT
Phathom Pharmaceuticals
RESEARCH TOOLSreports
Want to see PHAT full AI Analyst Report?

Phathom Pharmaceuticals (PHAT) Stock News & Sentiment

607 Followers
Phathom’s Vonoprazan Trial Targets Episodic Heartburn Upside for PHAT Investors
Premium
Company Announcements
Phathom’s Vonoprazan Trial Targets Episodic Heartburn Upside for PHAT Investors
16h ago
PHAT
Phathom Starts Phase 3 VOQUEZNA Trial in NERD
Premium
Company Announcements
Phathom Starts Phase 3 VOQUEZNA Trial in NERD
8d ago
8K
PHAT
Phathom Pharmaceuticals’ Earnings Call Signals Profitable Growth
Premium
Company Announcements
Phathom Pharmaceuticals’ Earnings Call Signals Profitable Growth
2M ago
PHAT
Phathom Pharmaceuticals: Strong VOQUEZNA Momentum and Pipeline Progress Support Maintained $26 Price Target and Buy Rating
Premium
Ratings
Phathom Pharmaceuticals: Strong VOQUEZNA Momentum and Pipeline Progress Support Maintained $26 Price Target and Buy Rating
2M ago
PHAT
Phathom Completes Enrollment in Eosinophilic Esophagitis Trial
Premium
Company Announcements
Phathom Completes Enrollment in Eosinophilic Esophagitis Trial
4M ago
8K
PHAT
Analyst Reaffirms Buy on Phathom as Voquezna Momentum Builds; $28 Price Target Maintained
Premium
Ratings
Analyst Reaffirms Buy on Phathom as Voquezna Momentum Builds; $28 Price Target Maintained
4M ago
PHAT
Phathom Shareholders Reaffirm Board, Pay and Auditor
Premium
Company Announcements
Phathom Shareholders Reaffirm Board, Pay and Auditor
5M ago
8K
PHAT
More PHAT News >

PHAT News on the Web

Phathom Starts Phase 3 VOQUEZNA Trial in NERD
TipRanks News
Neutral
Phathom Pharmaceuticals’ Earnings Call Signals Profitable Growth
TipRanks News
Bullish
Analysts Conflicted on These Healthcare Names: Phathom Pharmaceuticals (PHAT) and Elicio Therapeutics (ELTX)
TipRanks News
Bullish
Phathom Pharma Completes Enrollment In Phase 2 PHalcon-EoE-201 For Eosinophilic Esophagitis
rttnews
Bullish
Phathom Pharmaceuticals completes enrollment in pHalcon-EoE-201 clinical trial
TipRanks News
Bullish
Needham pharmaceuticals analysts hold analyst/industry conference call
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Climb Bio (CLYM), Humacyte (HUMA) and Phathom Pharmaceuticals (PHAT)
TipRanks News
Bullish
Phathom Shareholders Reaffirm Board, Pay and Auditor
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
PHAT
Sector Average
Media Buzz
This Week1 articles
Weekly Average1.25 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is PHAT’s Media Buzz Sentiment?
1 articles about PHAT were published this week. In an average week, 1.25 articles are published.
    What is PHAT’s weekly average amount of articles?
    In an average week, 1.25 articles about PHAT are published.
      What is PHAT’s News Sentiment?
      100% of articles about PHAT were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        XENEXenon
        ABTAbbott Laboratories
        BBIOBridgeBio Pharma
        BDXBecton Dickinson
        NVSNovartis
        Showing the stocks with the most bullish news sentiment over the past week